title: Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States.
abstract: BACKGROUND
  Neuropathic pain (NeP) can be chronic, debilitating, and can interfere with sleep, functioning, and emotional well being. While there are multiple causes of NeP, few studies have examined the disease burden and treatment patterns associated with post-traumatic/post-surgical (PTPS) NeP.
  
  
  OBJECTIVE
  To characterize pain, health status, function, health care resource utilization, lost productivity, and costs among subjects with PTPS NeP in the United States.
  
  
  METHODS
  This observational study enrolled 100 PTPS NeP subjects recruited during routine visits from general practitioner and specialist sites. Subjects completed a one-time questionnaire with validated measures of pain severity and pain interference, health status, sleep, anxiety and depression, productivity, and study-specific items on demographics, employment status, and out-of-pocket expenses. Investigators completed a case report form based on a 6-month retrospective chart review, recording subjects' clinical characteristics as well as current and previous medications/treatments for NeP. Subjects were stratified into mild, moderate, and severe pain groups.
  
  
  RESULTS
  Subjects' demographic characteristics were: mean age of 54.9 years, 53% female, and 22% employed for pay. Mean pain severity score was 5.6 (0-10 scale), with 48% and 35% classified as having moderate and severe pain, respectively. The mean number of comorbidities increased with greater pain severity (P = 0.0009). Patient-reported outcomes were worse among PTPS NeP subjects with more severe pain, including pain interference with function, health state utility, sleep, and depression (P < 0.0001). Eighty-two percent of subjects were prescribed two or more NeP medications. The total mean annualized adjusted direct and indirect costs per subject were $11,846 and $29,617, respectively. Across pain severity levels, differences in annualized adjusted direct and indirect costs were significant (P < 0.0001).
  
  
  CONCLUSIONS
  PTPS NeP subjects reported high pain scores, which were associated with poor health utility, sleep, mood, and function, as well as high health care resource utilization and costs. The quality of life impact and costs attributable to PTPS NeP suggest an unmet need for effective and comprehensive management.
authors.affiliation: Pfizer, Inc, New York, NY, USA.
authors.forename: Bruce
authors.initials: B
authors.lastname: Parsons
authors.forename: Caroline
authors.initials: C
authors.lastname: Schaefer
authors.forename: Rachael
authors.initials: R
authors.lastname: Mann
authors.forename: Alesia
authors.initials: A
authors.lastname: Sadosky
authors.forename: Shoshana
authors.initials: S
authors.lastname: Daniel
authors.forename: Srinivas
authors.initials: S
authors.lastname: Nalamachu
authors.forename: Brett R
authors.initials: BR
authors.lastname: Stacey
authors.forename: Edward C
authors.initials: EC
authors.lastname: Nieshoff
authors.forename: Michael
authors.initials: M
authors.lastname: Tuchman
authors.forename: Alan
authors.initials: A
authors.lastname: Anschel
keywords: costs; neuropathic pain; patient-reported outcomes; productivity; quality-of-life; trauma/surgery